Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
TREM2 ectodomain and its soluble form in Alzheimer’s disease
by
Xiong, Min
, Fu, Zhihui
, Zhang, Zhentao
, Meng, Lanxia
, Zhang, Xingyu
, Yang, Jiaolong
in
Alzheimer's disease
/ Amino acids
/ Binding sites
/ Biomedical and Life Sciences
/ Biomedicine
/ Brain research
/ Care and treatment
/ Cerebrospinal fluid
/ Dementia
/ Diagnosis
/ Disease
/ Health aspects
/ Immune response
/ Immunoglobulins
/ Immunology
/ Ligands
/ Membrane proteins
/ Metalloproteinase
/ Microglia
/ Myeloid cells
/ Neurobiology
/ Neurodegenerative diseases
/ Neuroinflammation
/ Neurology
/ Neurosciences
/ Proteins
/ Review
/ Structure-function relationships
/ Tau protein
/ Triggering receptor expressed on myeloid cells 2
2020
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
TREM2 ectodomain and its soluble form in Alzheimer’s disease
by
Xiong, Min
, Fu, Zhihui
, Zhang, Zhentao
, Meng, Lanxia
, Zhang, Xingyu
, Yang, Jiaolong
in
Alzheimer's disease
/ Amino acids
/ Binding sites
/ Biomedical and Life Sciences
/ Biomedicine
/ Brain research
/ Care and treatment
/ Cerebrospinal fluid
/ Dementia
/ Diagnosis
/ Disease
/ Health aspects
/ Immune response
/ Immunoglobulins
/ Immunology
/ Ligands
/ Membrane proteins
/ Metalloproteinase
/ Microglia
/ Myeloid cells
/ Neurobiology
/ Neurodegenerative diseases
/ Neuroinflammation
/ Neurology
/ Neurosciences
/ Proteins
/ Review
/ Structure-function relationships
/ Tau protein
/ Triggering receptor expressed on myeloid cells 2
2020
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
TREM2 ectodomain and its soluble form in Alzheimer’s disease
by
Xiong, Min
, Fu, Zhihui
, Zhang, Zhentao
, Meng, Lanxia
, Zhang, Xingyu
, Yang, Jiaolong
in
Alzheimer's disease
/ Amino acids
/ Binding sites
/ Biomedical and Life Sciences
/ Biomedicine
/ Brain research
/ Care and treatment
/ Cerebrospinal fluid
/ Dementia
/ Diagnosis
/ Disease
/ Health aspects
/ Immune response
/ Immunoglobulins
/ Immunology
/ Ligands
/ Membrane proteins
/ Metalloproteinase
/ Microglia
/ Myeloid cells
/ Neurobiology
/ Neurodegenerative diseases
/ Neuroinflammation
/ Neurology
/ Neurosciences
/ Proteins
/ Review
/ Structure-function relationships
/ Tau protein
/ Triggering receptor expressed on myeloid cells 2
2020
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
TREM2 ectodomain and its soluble form in Alzheimer’s disease
Journal Article
TREM2 ectodomain and its soluble form in Alzheimer’s disease
2020
Request Book From Autostore
and Choose the Collection Method
Overview
Triggering receptor expressed on myeloid cells 2 (TREM2) is a receptor mainly expressed on the surface of microglia. It mediates multiple pathophysiological processes in various diseases. Recently, TREM2 has been found to play a role in the development of Alzheimer’s disease (AD). TREM2 is a transmembrane protein that is specifically expressed on microglia in the brain. It contains a long ectodomain that directly interacts with the extracellular environment to regulate microglial function. The ectodomain of TREM2 is processed by a disintegrin and metalloprotease, resulting in the release of a soluble form of TREM2 (sTREM2). Recent studies have demonstrated that sTREM2 is a bioactive molecule capable of binding ligands, activating microglia, and regulating immune responses during the AD continuum. Clinical studies revealed that sTREM2 level is elevated in cerebrospinal fluid (CSF) of AD patients, and the sTREM2 level is positively correlated with the levels of classical CSF biomarkers, namely t-tau and p-tau, indicating that it is a reliable predictor of the early stages of AD. Herein, we summarize the key results on the generation, structure, and function of sTREM2 to provide new insights into TREM2-related mechanisms underlying AD pathogenesis and to promote the development of TREM2-based therapeutic strategy.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
This website uses cookies to ensure you get the best experience on our website.